U.S., Nov. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07237009) titled 'Effects of Personalized Digital Reminiscence Therapy on Patients With Neurocognitive Disorders' on Sept. 24.
Brief Summary: This study aims to observe the effects of daily personalized digital reminiscence sessions, conducted with the help of a digital conversational agent, and to determine whether these sessions lead to improvements in symptoms such as apathy and depression.
The researchers therefore seek to observe whether this daily use can improve certain aspects of well-being, such as motivation, mood, sleep quality, quality of life, and engagement with the tool.
The study also aims to assess whether simple reminders delivere...